Jacqueline Fidanza
Chief Operating Officer at Scale Biosciences, Inc.
Profile
Jacqueline Fidanza currently works at Scale Biosciences, Inc., as Chief Operating Officer from 2023.
Jacqueline Fidanza active positions
| Companies | Position | Start |
|---|---|---|
Scale Biosciences, Inc.
 Scale Biosciences, Inc. Medical SpecialtiesHealth Technology Scale Biosciences, Inc. is an American single-cell sequencing solutions company that aims to unlock the potential of single-cell analysis at scale by eliminating barriers to discovery. The private company has R & D facilities in Menlo Park, CA and another location that is not specified. The company is located in the US. Scalebio is financed by leading life sciences tools investors Arch Venture Partners, BNG, and Tao Capital. The company's multidisciplinary team of scientists and technologists has combined expertise in next-generation sequencing, genomics, proteomics, and bioinformatics. Discover how their single-cell sequencing technology enables scalable sample indexing, cell throughput, and multi-omics analysis. | Chief Operating Officer | 2023-06-30 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Scale Biosciences, Inc.
Scale Biosciences, Inc. Medical SpecialtiesHealth Technology Scale Biosciences, Inc. is an American single-cell sequencing solutions company that aims to unlock the potential of single-cell analysis at scale by eliminating barriers to discovery. The private company has R & D facilities in Menlo Park, CA and another location that is not specified. The company is located in the US. Scalebio is financed by leading life sciences tools investors Arch Venture Partners, BNG, and Tao Capital. The company's multidisciplinary team of scientists and technologists has combined expertise in next-generation sequencing, genomics, proteomics, and bioinformatics. Discover how their single-cell sequencing technology enables scalable sample indexing, cell throughput, and multi-omics analysis. | Health Technology |
- Stock Market
- Insiders
- Jacqueline Fidanza
